Universe Pharmaceuticals INC
UPC
$2.91
-$0.71-19.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 23.02M | 26.73M | 29.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 23.02M | 26.73M | 29.52M |
| Cost of Revenue | -- | -- | 16.95M | 19.17M | 20.58M |
| Gross Profit | -- | -- | 6.07M | 7.56M | 8.94M |
| SG&A Expenses | -- | -- | 11.07M | 10.70M | 10.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -9.80K | 36.20K | 66.30K |
| Total Operating Expenses | -- | -- | 31.04M | 32.58M | 34.43M |
| Operating Income | -- | -- | -8.02M | -5.86M | -4.91M |
| Income Before Tax | -- | -- | -18.83M | -17.02M | -10.68M |
| Income Tax Expenses | -- | -- | 606.80K | 1.94M | 2.10M |
| Earnings from Continuing Operations | -- | -- | -19.44 | -18.97 | -12.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -19.44M | -18.97M | -12.77M |
| EBIT | -- | -- | -8.02M | -5.86M | -4.91M |
| EBITDA | -- | -- | -7.53M | -5.36M | -4.41M |
| EPS Basic | -- | -- | -291.20 | -- | -- |
| Normalized Basic EPS | -- | -- | -183.57 | -- | -- |
| EPS Diluted | -- | -- | -291.20 | -- | -- |
| Normalized Diluted EPS | -- | -- | -183.57 | -- | -- |
| Average Basic Shares Outstanding | -- | -- | 43.60K | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | 43.60K | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |